Mitsubishi Tanabe Pharma Corporation

02/05/2020 | Press release | Distributed by Public on 02/04/2020 22:53

Mitsubishi Tanabe Pharma expands domestic co-promotion framework for STELARA. An application for an additional indication has been filed for ulcerative colitis, which will be[...]